Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Is Mistletoe Treatment Beneficial in Invasive Breast Cancer? A New Approach to an Unresolved Problem

PETER FRITZ, JÜRGEN DIPPON, SIMON MÜLLER, SVEN GOLETZ, CHRISTIAN TRAUTMANN, XENOPHON PAPPAS, GERMAN OTT, HILTRUD BRAUCH, MATTHIAS SCHWAB, STEFAN WINTER, THOMAS MÜRDTER, FRIEDHELM BRINKMANN, SIMONE FAISST, SUSANNE RÖSSLE, ANDREAS GERTEIS and GODEHARD FRIEDEL
Anticancer Research March 2018, 38 (3) 1585-1593;
PETER FRITZ
1Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JÜRGEN DIPPON
2Institute of Stochastics and Applications, University of Stuttgart, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIMON MÜLLER
2Institute of Stochastics and Applications, University of Stuttgart, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SVEN GOLETZ
2Institute of Stochastics and Applications, University of Stuttgart, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTIAN TRAUTMANN
3Department of Gynecology and Obstetrics, Robert-Bosch-Hospital, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
XENOPHON PAPPAS
4Radiologie Nuklearmedizin Winnenden, Winnenden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GERMAN OTT
1Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HILTRUD BRAUCH
5Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATTHIAS SCHWAB
5Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany
6Department of Clinical Pharmacology, University Hospital Tuebingen, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFAN WINTER
5Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THOMAS MÜRDTER
5Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRIEDHELM BRINKMANN
7Onkologischer Schwerpunkt Stuttgart e.V., Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIMONE FAISST
7Onkologischer Schwerpunkt Stuttgart e.V., Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUSANNE RÖSSLE
7Onkologischer Schwerpunkt Stuttgart e.V., Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREAS GERTEIS
3Department of Gynecology and Obstetrics, Robert-Bosch-Hospital, Stuttgart, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GODEHARD FRIEDEL
8Center for Pulmonology and Thoracic Surgery, Klinik Schillerhöhe, Stuttgart-Gerlingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: godehard.friedel@klinik-schillerhoehe.de
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 38 no. 3 1585-1593
PubMed 
29491089

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received December 11, 2017
  • Revision received January 16, 2018
  • Accepted January 17, 2018
  • Published online February 28, 2018.

Copyright & Usage 
Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. PETER FRITZ1,
  2. JÜRGEN DIPPON2,
  3. SIMON MÜLLER2,
  4. SVEN GOLETZ2,
  5. CHRISTIAN TRAUTMANN3,
  6. XENOPHON PAPPAS4,
  7. GERMAN OTT1,
  8. HILTRUD BRAUCH5,
  9. MATTHIAS SCHWAB5,6,
  10. STEFAN WINTER5,
  11. THOMAS MÜRDTER5,
  12. FRIEDHELM BRINKMANN7,
  13. SIMONE FAISST7,
  14. SUSANNE RÖSSLE7,
  15. ANDREAS GERTEIS3 and
  16. GODEHARD FRIEDEL8⇑
  1. 1Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany
  2. 2Institute of Stochastics and Applications, University of Stuttgart, Stuttgart, Germany
  3. 3Department of Gynecology and Obstetrics, Robert-Bosch-Hospital, Stuttgart, Germany
  4. 4Radiologie Nuklearmedizin Winnenden, Winnenden, Germany
  5. 5Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany
  6. 6Department of Clinical Pharmacology, University Hospital Tuebingen, Stuttgart, Germany
  7. 7Onkologischer Schwerpunkt Stuttgart e.V., Stuttgart, Germany
  8. 8Center for Pulmonology and Thoracic Surgery, Klinik Schillerhöhe, Stuttgart-Gerlingen, Germany
  1. Correspondence to: Godehard Friedel, Klinik Schillerhöhe, Center for Pulmonology and Thoracic Surgery, Solitudestr. 18, 70839 Stuttgart, Germany. Tel: +49 71562037241, Fax: +49 71562037003, e-mail: godehard.friedel{at}klinik-schillerhoehe.de
View Full Text

Cited By...

  • 5 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 38 (3)
Anticancer Research
Vol. 38, Issue 3
March 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Is Mistletoe Treatment Beneficial in Invasive Breast Cancer? A New Approach to an Unresolved Problem
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Is Mistletoe Treatment Beneficial in Invasive Breast Cancer? A New Approach to an Unresolved Problem
PETER FRITZ, JÜRGEN DIPPON, SIMON MÜLLER, SVEN GOLETZ, CHRISTIAN TRAUTMANN, XENOPHON PAPPAS, GERMAN OTT, HILTRUD BRAUCH, MATTHIAS SCHWAB, STEFAN WINTER, THOMAS MÜRDTER, FRIEDHELM BRINKMANN, SIMONE FAISST, SUSANNE RÖSSLE, ANDREAS GERTEIS, GODEHARD FRIEDEL
Anticancer Research Mar 2018, 38 (3) 1585-1593;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Is Mistletoe Treatment Beneficial in Invasive Breast Cancer? A New Approach to an Unresolved Problem
PETER FRITZ, JÜRGEN DIPPON, SIMON MÜLLER, SVEN GOLETZ, CHRISTIAN TRAUTMANN, XENOPHON PAPPAS, GERMAN OTT, HILTRUD BRAUCH, MATTHIAS SCHWAB, STEFAN WINTER, THOMAS MÜRDTER, FRIEDHELM BRINKMANN, SIMONE FAISST, SUSANNE RÖSSLE, ANDREAS GERTEIS, GODEHARD FRIEDEL
Anticancer Research Mar 2018, 38 (3) 1585-1593;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A Novel Filtration Membrane for Clustered Circulating Tumor Cell Extraction: A Prospective Feasibility Study
  • Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
  • Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study
Show more Clinical Studies

Similar Articles

Keywords

  • ML 1
  • breast cancer treatment
  • complementary medicine
  • prognosis
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire